Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
November 15, 2023
One of the most salient lessons from the pandemic is the need to diversify manufacturing capabilities and bolster supply resilience to avoid a repeat of the slow and inequitable vaccine roll out in African countries. To turn this lesson into action, the Gavi Secretariat is rapidly advancing plans fo...
Blog Post
August 16, 2023
Despite verbal nods to global cooperation, equity, and solidarity, the COVID-19 pandemic laid bare a brutal realpolitik: all countries will put their citizens first and vaccinate their own populations, before offering charitable leftovers beyond their own borders. Sub-Saharan Africa, more than any o...
Blog Post
August 07, 2023
While donors are increasingly interested in both promoting evidence-based policymaking and advancing locally led development, the two agendas have often remained separate. This is a missed opportunity. A recent CGD working group underscored the value of locally immersed researchers and organizations...
Blog Post
January 20, 2022
In the wake of the COVID-19 crisis, many sub-Saharan African countries will face serious economic crises and shrinking public spending. If countries are unable to spend more, they need to spend better. Europe has leading expertise in building institutions for priority-setting in health, making it an...
Blog Post
April 24, 2020
Last week, the president of Malawi announced the country would impose a strict 21-day lockdown starting on April 18 to stem the spread of coronavirus. We outline the main aspects of Malawi’s proposed lockdown policy, and examine the extent to which a country such as Malawi is prepared and able...
Blog Post
April 21, 2016
Are genetically modified organisms (GMOs) likely to play a significant role in tackling malnutrition and reducing poverty in Africa? Our short answer is "it depends." In a new CGD policy paper and brief, we examine the evidence and conclude that currently available GMOs are ...